About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
Structural biology and organic chemistry-based human therapies and drugs
Structural biology and organic chemistry-based human therapies and drugs
Sectors
Healthcare
Life Sciences
First Invested
1989
Early
Company Status
IPO/Public
NASDAQ: VRTX